The global burden of degenerative mitral valve disease is rising annually, highlighting the need for targeted screening at age 65 and sex-stratified public health interventions.
The number of DMVD epidemiological indicators is rising annually. Higher-SDI countries need to adjust healthcare policies to address aging populations and support lower-SDI countries with medical resources and cardiology expertise. This study suggests that age 65 is a meaningful threshold for screening. Additionally, Our findings advocate for stratified public health interventions: incidence-based screening targeting males and mortality-focused treatment intensification for females.
Si et al. (Wed,) studied this question.